Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Patel JT"'
Autor:
Shah JM; Internal Medicine, GCS Medical College Hospital and Research Centre, Ahmedabad, IND., Patel JT; Internal Medicine, GCS Medical College Hospital and Research Centre, Ahmedabad, IND., Shah H; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA., Dadigiri H; Internal Medicine, Saint Clare's Hospital, New Jersey, USA., Alla A; Internal Medicine, Saint Clare's Hospital, New Jersey, USA., Cheriyath P; Internal Medicine, Hackensack Meridian - Ocean Medical Center, Brick, USA.
Publikováno v:
Cureus [Cureus] 2023 Aug 15; Vol. 15 (8), pp. e43513. Date of Electronic Publication: 2023 Aug 15 (Print Publication: 2023).
Autor:
Dhameliya TM; L. M. College of Pharmacy, Navrangpura, Ahmedabad, 380 009, Gujarat, India. Electronic address: tejasm.dhameliya@nirmauni.ac.in., Vekariya DD; L. M. College of Pharmacy, Navrangpura, Ahmedabad, 380 009, Gujarat, India., Patel HY; L. M. College of Pharmacy, Navrangpura, Ahmedabad, 380 009, Gujarat, India., Patel JT; L. M. College of Pharmacy, Navrangpura, Ahmedabad, 380 009, Gujarat, India.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2023 Jul 05; Vol. 255, pp. 115409. Date of Electronic Publication: 2023 Apr 21.
Autor:
Thotamgari SR; Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana., Sheth AR; Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana., Patel HP; Department of Internal Medicine, Louis A. Weiss Memorial Hospital, Chicago, Illinois., Bretzman J; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota., Ward RC; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota., Thakkar S; Department of Internal Medicine, Rochester General Hospital, Rochester, New York., Patel JT; G.C.S. Medical College, Hospital and Research Center, Ahmedabad, India., Asirvatham SJ; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota., Holmes DR Jr; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota., Egbe A; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota., Deshmukh A; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota., DeSimone CV; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: desimone.christopher@mayo.edu.
Publikováno v:
Heart rhythm [Heart Rhythm] 2022 Aug; Vol. 19 (8), pp. 1392-1393. Date of Electronic Publication: 2022 Apr 28.
Autor:
Patel JT; School of Life Sciences, University of Nottingham, Medical School, QMC, Nottingham NG7 2UH, UK., Belsham HR; School of Life Sciences, University of Nottingham, Medical School, QMC, Nottingham NG7 2UH, UK., Rathbone AJ; School of Life Sciences, University of Nottingham, Medical School, QMC, Nottingham NG7 2UH, UK., Wickstead B; School of Life Sciences, University of Nottingham, Medical School, QMC, Nottingham NG7 2UH, UK., Gell C; School of Life Sciences, University of Nottingham, Medical School, QMC, Nottingham NG7 2UH, UK., Friel CT; School of Life Sciences, University of Nottingham, Medical School, QMC, Nottingham NG7 2UH, UK claire.friel@nottingham.ac.uk.
Publikováno v:
Open biology [Open Biol] 2016 Oct; Vol. 6 (10).
Autor:
Rich AL; Department of Environmental and Occupational Health Sciences, University of North Texas Health Science Center, Fort Worth, TX, USA.; WHO Chemical Risk Assessment Network., Patel JT; Department of Environmental and Occupational Health Sciences, University of North Texas Health Science Center, Fort Worth, TX, USA., Al-Angari SS; Department of Environmental and Occupational Health Sciences, University of North Texas Health Science Center, Fort Worth, TX, USA.
Publikováno v:
Environmental health insights [Environ Health Insights] 2016 Mar 28; Vol. 10, pp. 51-7. Date of Electronic Publication: 2016 Mar 28 (Print Publication: 2016).
Autor:
Rich AL; Department of Environmental & Occupational Health Sciences, School of Public Health, University of North Texas Health Science Center, Fort Worth, TX, USA., Patel JT; Department of Environmental & Occupational Health Sciences, School of Public Health, University of North Texas Health Science Center, Fort Worth, TX, USA.
Publikováno v:
Environmental health insights [Environ Health Insights] 2015 May 10; Vol. 9 (Suppl 1), pp. 35-9. Date of Electronic Publication: 2015 May 10 (Print Publication: 2015).
Autor:
Goldspiel B; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health., Hoffman JM; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health., Griffith NL; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health., Goodin S; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health., DeChristoforo R; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health., Montello CM; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health., Chase JL; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health., Bartel S; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health., Patel JT; Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2015 Apr 15; Vol. 72 (8), pp. e6-e35.
Autor:
Patel JT; School of Life Sciences, University of Nottingham., Belsham HR; School of Life Sciences, University of Nottingham., Rathbone AJ; School of Life Sciences, University of Nottingham., Friel CT; School of Life Sciences, University of Nottingham; claire.friel@nottingham.ac.uk.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2014 Oct 17 (92), pp. e52142. Date of Electronic Publication: 2014 Oct 17.
Autor:
Patel JT; a Department of Biochemistry; University of Leicester; Leicester, UK., Bottrill A, Prosser SL, Jayaraman S, Straatman K, Fry AM, Shackleton S
Publikováno v:
Nucleus (Austin, Tex.) [Nucleus] 2014 Sep-Oct; Vol. 5 (5), pp. 462-73.
Autor:
Haque F; Department of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom., Mazzeo D, Patel JT, Smallwood DT, Ellis JA, Shanahan CM, Shackleton S
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2010 Jan 29; Vol. 285 (5), pp. 3487-98. Date of Electronic Publication: 2009 Nov 21.